These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6154664)

  • 21. Cell-mediated suppression of tumor immunity has a non-specific component. I. Evidence from transplantation tests.
    Hellström KE; Hellström I
    Int J Cancer; 1981; 27(4):481-5. PubMed ID: 6168591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenic strength of sarcomas induced by methylcholanthrene in millipore filter diffusion chambers.
    Parmiani G; Carbone G; Lembo R
    Cancer Res; 1973 Apr; 33(4):750-4. PubMed ID: 4696474
    [No Abstract]   [Full Text] [Related]  

  • 23. Cell-mediated cytotoxicity to chemically-induced rat tumours.
    Zöller M; Price MR; Baldwin RW
    Int J Cancer; 1975 Oct; 16(4):593-606. PubMed ID: 170224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotherapy of a carcinogen-induced murine sarcoma with soluble tumor-specific transplantation antigens.
    Kahan BD; Tanaka T; Pellis NR
    J Natl Cancer Inst; 1980 Nov; 65(5):1001-4. PubMed ID: 6159495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissociation of anti-tumor immune responses in rats immunized with solubilized tumor-associated antigens from a methylcholanthrene-induced fibrosarcoma.
    Minami A; Mizushima Y; Takeichi N; Hosokawa M; Kobayashi H
    Int J Cancer; 1979 Mar; 23(3):358-65. PubMed ID: 437918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonimmunogenic sarcomas induced by 3-methylcholanthrene treatment of murine fibroblasts in diffusion chambers.
    Carbone G; Parmiani G
    J Natl Cancer Inst; 1975 Nov; 55(5):1195-7. PubMed ID: 1206746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotherapy of autochthomous rat methylcholanthrene-induced sarcomas with a mixture of allogeneic tumor cells and BCG-CWS.
    Kudo H; Suga M; Waga T; Ogasawara M; Sato T; Usubuchi I
    Tohoku J Exp Med; 1980 Jan; 130(1):49-53. PubMed ID: 7368205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of BCG infection on growth of 3-methylcholanthrene-induced rat sarcomas.
    Baldwin RW; Pimm MV
    Rev Eur Etud Clin Biol; 1971 Nov; 16(9):875-81. PubMed ID: 4945964
    [No Abstract]   [Full Text] [Related]  

  • 29. Relationship of tumor-specific transplantation antigens to the histocompatibility complex: dissociation of in vitro alloantigen expression and in vivo alloimmunity from tumor-specific transplantation antigen strength.
    Chauvenet PH; Smith RT
    Int J Cancer; 1978 Jul; 22(1):79-90. PubMed ID: 79560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Subcutaneous injection of spleen cells from mice bearing large methylcholanthrene-induced sarcoma enhances subcutaneous tumors and artificial pulmonary metastases].
    Tsuchiya K; Yamagishi H; Hamada H; Komichi H; Oka T; Tanaka T; Inaba S
    Nihon Geka Gakkai Zasshi; 1987 Jul; 88(7):826-31. PubMed ID: 2444868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are methylcholanthrene-induced sarcoma-associated, rejection-inducing (TSTA) antigens, modified forms of H-2 or linked determinants?
    Klein G; Klein E
    Int J Cancer; 1975 Jun; 15(6):879-87. PubMed ID: 50291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cells from chemically induced mouse sarcomas retain tumor-specific transplantation antigenicity during prolonged passage in vitro.
    Walker R; Hellström I; Hellström KE
    Int J Cancer; 1980 Mar; 25(3):345-8. PubMed ID: 7390657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of high- and low-metastatic clones derived from a methylcholanthrene-induced murine fibrosarcoma.
    Wang N; Yu SH; Liener IE; Hebbel RP; Eaton JW; McKhann CF
    Cancer Res; 1982 Mar; 42(3):1046-51. PubMed ID: 6174210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation of transplanted 3-methylcholanthrene-induced sarcomas in mice by specific immune ahd by normal serum.
    Biddle C
    Int J Cancer; 1976 Jun; 17(6):755-64. PubMed ID: 947855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The roles of two peritoneal T-lymphocyte populations in the in vivo rejection of methylcolanthrene-induced sarcoma.
    Kadhim SA; Rees RC; Barrington-Leigh J
    Cell Immunol; 1985 Jan; 90(1):234-41. PubMed ID: 2578328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigenic diversity of tumors chemically induced within the progeny of a single cell.
    Basombrío MA; Prehn RT
    Int J Cancer; 1972 Jul; 10(1):1-8. PubMed ID: 4122455
    [No Abstract]   [Full Text] [Related]  

  • 37. Histologic host response to primary methylcholanthrene-induced sarcomas in rats immunized with allogeneic tumors.
    Kudo H; Sato T; Kakisaka Y; Nishimura S; Kano M
    Tohoku J Exp Med; 1975 Nov; 117(3):283-8. PubMed ID: 1202658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BCG immunotherapy of pulmonary growths from intravenously transferred rat tumour cells.
    Baldwin RW; Pimm MV
    Br J Cancer; 1973 Jan; 27(1):48-54. PubMed ID: 4686177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Further evidence of common antigenic properties in chemically induced sarcomas of mice.
    Reiner J; Southam CM
    Cancer Res; 1969 Oct; 29(10):1814-20. PubMed ID: 5823950
    [No Abstract]   [Full Text] [Related]  

  • 40. [Heterogeneity of murine sarcoma cells for transplantability due to their different susceptibilities to the lytic action of macrophages].
    Ustinov AS; Lavrovskiĭ VA
    Biull Eksp Biol Med; 1988 Mar; 105(3):322-4. PubMed ID: 3349171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.